Studies report increased m6A methylation in ALS spinal cord tissue, with mutations in Fused in sarcoma (FUS) and TDP-43 linked to altered m6A signaling pathways contributing to disease pathology [75,76,77]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.